14 These AEs can significantly impact a patients quality of life, leading to decreased adherence, limitation of dose escalations, and, in some cases, treatment discontinuation
Crosstalk between gut microbiota and host immunity: impact on inflammation and immunotherapy
Eligibility, treatment initiation, and continuation are determined solely by licensed clinicians following individualized medical review

The findings established Ipamorelin's defining characteristic: Growth hormone Ipamorelin produced dose-dependent GH release comparable to GHRP-6 Cortisol No significant cortisol elevation was observed with Ipamorelin, while GHRP-2 and GHRP-6 produced measurable cortisol increases Prolactin No significant prolactin elevation at GH-effective concentrations ACTH No significant ACTH stimulation, contrasting with the adrenocorticotropic effects of other GHRPs GHRP Selectivity Comparison (Preclinical Data) Compound GH Release Cortisol Effect Prolactin Effect ACTH Effect Ipamorelin Dose-dependent Minimal / none Minimal / none Minimal / none GHRP-2 Dose-dependent Moderate increase Moderate increase Moderate increase GHRP-6 Dose-dependent Moderate increase Moderate increase Moderate increase Hexarelin Strong Significant increase Significant increase Significant increase Data adapted from Raun et al

Rogan was then asked to list what specific peptides he recommends, and he gave three: BPC-157: Wound-Healing & Cell Regeneration BPC-157, or Body Protecting Compound 157 is a naturally-occurring oligopeptide made of 15 amino acids
For soft tissue injuries, inject close to the injury site using a SubQ or IM method